Abstract:Aberrant sympathetic nerve activity exacerbates cardiovascular risk in hypertension and diabetes, which are common comorbidities, yet clinically sympathetic nerve activity remains poorly controlled. The hypertensive diabetic state is associated with increased reflex sensitivity and tonic drive from the peripheral chemoreceptors, the cause of which is unknown. We have previously shown hypertension to be critically dependent on the carotid body (CB) input in spontaneously hypertensive rat, a model that also exhibits a number of diabetic traits. CB overstimulation by insulin and leptin has been similarly implicated in the development of increased sympathetic nerve activity in metabolic syndrome and obesity. Thus, we hypothesized that in hypertensive diabetic state (spontaneously hypertensive rat), the CB is sensitized by altered metabolic signaling causing excessive sympathetic activity levels and dysfunctional reflex regulation. Using a hypothesis-free RNA-seq approach, we investigated potential molecular targets implicated in energy metabolism mediating CB sensitization and its regulation of sympathetic outflow in experimental hypertension. Identified targets were characterized using molecular and functional techniques assessing peripheral chemoreflex sensitivity in situ and in vivo. We discovered GLP1R (glucagon-like peptide-1 receptor) expression in the CBs of rat and human and showed that its decreased expression is linked to sympathetic hyperactivity in rats with cardiometabolic disease. We demonstrate GLP1R to be localized to CB chemosensory cells, while targeted administration of GLP1R agonist to the CB lowered its basal discharge and attenuated chemoreflex-evoked blood pressure and sympathetic responses. Importantly, hyperglycemia-induced peripheral chemoreflex sensitization and associated basal sympathetic overactivity were abolished by GLP1R activation in the CB suggesting a role in a homeostatic response to high blood glucose. We show GLP1 (glucagon-like peptide-1) to modulate the peripheral chemoreflex acting on the CB, supporting this organ as a multimodal receptor. Our findings pinpoint CBs as potential targets for ameliorating excessive sympathetic activity using GLP1R agonists in the hypertensive-diabetic condition. Download figure Download PowerPoint

Topography of the GLP-1/GLP-1 receptor system in the spinal cord of male mice

Characterization of the Glucagonlike Peptide-1 Receptor in Male Mouse Brain Using a Novel Antibody and In Situ Hybridization

Phosphate-Activated Glutaminase-Containing Neurons in the Rat Paraventricular Nucleus Express Angiotensin Type 1 Receptors

Elevated Glucagon-like Peptide-1 Receptor Level in the Paraventricular Hypothalamic Nucleus of Type 2 Diabetes Mellitus Patients

Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons

GLP-1 programs the neurovascular landscape

Central Nervous System GLP-1 Receptors Regulate Islet Hormone Secretion and Glucose Homeostasis in Male Rats

Glucose-sensing glucagon-like peptide-1 receptor neurons in the dorsomedial hypothalamus regulate glucose metabolism

[Glucagon-like peptide 2, a neurotransmitter with a newly discovered role in the regulation of food ingestion]

Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation

A neuronal circuit driven by GLP-1 in the olfactory bulb regulates insulin secretion

GLP1R Attenuates Sympathetic Response to High Glucose via Carotid Body Inhibition

Structural and molecular characterization of paraventricular thalamic glucokinase-expressing neuronal circuits in the mouse

Comparative Study on Anorexigenic Effect of Glucagon-Like Peptide-1 Receptor Agonists in Rats.

Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding

The central GLP-1: implications for food and drug reward

GLP-1 modulated the firing activity of nigral dopaminergic neurons in both normal and parkinsonian mice

The physiology of glucagon-like peptide 1

State-dependent central synaptic regulation by GLP-1 is essential for energy homeostasis

Limited evidence for anatomical contacts between intestinal GLP-1 cells and vagal neurons in male mice

GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans